AI assistant
Sending…
Axogen, Inc. — Director's Dealing 2012
Sep 7, 2012
32414_dirs_2012-09-07_317bc8ab-e767-4a30-8c1f-530c46e7f051.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2011-10-10
Reporting Person: Mandato Joseph M (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-10-10 | Stock Option (Right to Buy) | $2.75 | A | 12000 | Acquired | 2018-10-10 | Common Stock (12000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1426392 | Indirect |
Footnotes
F1: The reporting person filed a Form 4 on February 13, 2012 reporting the acquisition of 5,455 shares of common stock on October 10, 2011. The shares were cancelled by the Issuer. As of October 10, 2011, the reporting person indirectly owned 1,426,392 shares of common stock.
More from Axogen, Inc.
Major Shareholding Notification
2026
May 7
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Interim / Quarterly Report
2026
Apr 28
Earnings Release
2026
Apr 28
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3